ALTO NEUROSCIENCE
Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most.
ALTO NEUROSCIENCE
Industry:
Artificial Intelligence (AI) Biopharma Biotechnology Neuroscience Precision Medicine
Founded:
2019-01-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.altoneuroscience.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
239.26 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Tag Manager Google Analytics Content Delivery Network Global Site Tag HSTS Google Analytics 4 Nginx
Similar Organizations
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
FogPharma
FogPharma creates a new class of medicines that target human disease drivers currently considered undruggable.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Alpha Wave Ventures
Alpha Wave Ventures investment in Series C - Alto Neuroscience
Point72 Ventures
Point72 Ventures investment in Series C - Alto Neuroscience
Alexandria Venture Investments
Alexandria Venture Investments investment in Series C - Alto Neuroscience
Alkeon Capital
Alkeon Capital investment in Series C - Alto Neuroscience
What If Ventures
What If Ventures investment in Series C - Alto Neuroscience
Franklin Templeton
Franklin Templeton investment in Series C - Alto Neuroscience
InVivium Capital
InVivium Capital investment in Series C - Alto Neuroscience
Eli Lilly
Eli Lilly investment in Series C - Alto Neuroscience
Windham Venture Partners
Windham Venture Partners investment in Series C - Alto Neuroscience
Lightswitch Capital
Lightswitch Capital investment in Series C - Alto Neuroscience
Key Employee Changes
Official Site Inspections
http://www.altoneuroscience.com Semrush global rank: 1.64 M Semrush visits lastest month: 14.11 K
- Host name: altoneuroscience.tempurl.host
- IP address: 140.82.49.122
- Location: San Jose United States
- Latitude: 37.3387
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95113
More informations about "Alto Neuroscience"
Alto Neuroscience - Crunchbase Company Profile
Contact Email [email protected] Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions.See details»
Pioneers in Precision Psychiatry | About Alto Neuroscience
Our team. Our work is propelled by a multidisciplinary team of experts with extensive experience in psychiatric drug development, neuroscience, and clinical psychiatry.See details»
Alto Neuroscience, Inc. - Investors
Nov 4, 2024 Contact us at [email protected]. View all news Latest News. View all events Latest Events. View all presentations Latest Presentation. Contact Us. 650 Castro …See details»
Alto Neuroscience Company Profile | Management and Employees …
Company Name. Alto Neuroscience. Main Industry. Research & Development, Business Services. Website. www.altoneuroscience.comSee details»
Alto Neuroscience - Overview, News & Similar companies
Mar 11, 2024 Alto Neuroscience contact info: Phone number: (773) 255-5012 Website: www.altoneuroscience.com What does Alto Neuroscience do? Alto Neuroscience is a clinical …See details»
Alto Neuroscience Company Profile - Office Locations ... - Craft
Oct 29, 2024 Alto Neuroscience is a biopharmaceutical company that develops medicines to treat psychiatric disorders. It develops a Biomarker AI-enabled platform that identifies …See details»
Alto Neuroscience - LinkedIn
ALTO-203 is a novel histamine H3 inverse agonist currently being evaluated in a Phase 2 #ClinicalTrial for the treatment of #MajorDepressiveDisorder with increased levels of …See details»
Alto Neuroscience, Inc. | VentureRadar
"Alto is transforming mental health by developing a new generation of psychiatric drugs that are more effective by virtue of personalization, achieved by integrating biomarkers into drug …See details»
Alto Neuroscience: Contact Details and Business Profile
Altoneuroscience.com; 3 847869XXXX; 312466XXXX; 773255XXXX; Faizan Badami Head of Data Engineering at Alto Neuroscience Palo Alto, CA, US View. 1 stanford.edu; 2 …See details»
Alto Neuroscience, Inc. - Alto Neuroscience Reports Full Year 2023 ...
Dec 31, 2023 LOS ALTOS, Calif.--(BUSINESS WIRE)-- Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today reported financial results for the full year ended December 31, 2023, and …See details»
Alto Neuroscience to Participate in Upcoming Investor Conferences
Nov 4, 2024 Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines forSee details»
Alto Neuroscience CEO and Key Executive Team | Craft.co
Alto Neuroscience's Founder, Chief Executive Officer & Director is Amit Etkin. Other executives include Wei Wu, Chief Data Science Officer; Adam Savitz, Chief Medical Officer and 6 others. …See details»
Alto Neuroscience, Inc. - Amit Etkin, M.D., Ph.D., Founder and CEO …
Jun 18, 2024 LOS ALTOS, Calif.--(BUSINESS WIRE)-- Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced that Amit Etkin, M.D., Ph.D., founder and CEO, was named an …See details»
Alto Neuroscience Emerges with Largest Clinical-Stage Precision ...
Oct 14, 2021 --Advancing 11 clinical-stage assets across psychiatric conditions with Phase 2 data readouts in MDD and PTSD for each of its three lead candidates expected by mid-2023-- …See details»
Our Precision Psychiatry Platform | Alto Neuroscience
Complex problems demand precise solutions. Mental health disorders are a leading cause of disability globally. 1 In the US alone, 1 in 5 people are living with a mental health disorder, with …See details»
Alto Neuroscience, Inc. - Alto Neuroscience Announces Data ...
May 9, 2024 LOS ALTOS, Calif.--(BUSINESS WIRE)-- Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced upcoming data presentations that highlight the company’s precision …See details»
Alto Neuroscience Inc. - Cruelty Free Investing
Company Website: https://www.altoneuroscience.com Contact: [email protected] ©2024 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit …See details»
Alto Neuroscience, Inc. - Alto Neuroscience Announces Data …
Dec 11, 2024 – Data generated from Alto’s precision psychiatry platform and clinical-stage product candidates highlighted across three poster presentations and a panel discussion – – …See details»
Apr 12, 2022 Press Release - Alto Neuroscience
LOS ALTOS, Calif., April 12, 2022 – Alto Neuroscience today announced the expansion of the company’s leadership team with the addition of Mikael Eliasson, M.D., Ph.D., as chief …See details»